U.S. Medical Equipment Stock News

Intuitive Surgical (ISRG) just secured CE mark approval for transvaginal gynecologic procedures on its da Vinci SP system in Europe, a world first that broadens the platform’s minimally invasive surgery footprint. That regulatory win lands at an interesting moment for Intuitive Surgical, with the stock at US$383.54 after a 6.4% 7-day share price return but a year-to-date share price decline of 31.75%, while the 3-year total shareholder return of 34.88% points to much stronger longer run...

Becton Dickinson (BDX) is back under the regulatory spotlight after a December 2024 SEC order found repeated misstatements around risks tied to its Alaris infusion pump, resulting in a US$175m civil penalty. The recent SEC order lands at a time when Becton Dickinson’s share price has already been through a sharp swing, with a 90 day share price return of 25.98%, a year to date share price decline of 6.96%, and a relatively modest 5 year total shareholder return of 2.03% that contrasts with a...

Mission Produce (AVO) just paired a sharp jump in third quarter revenue with new avocado production guidance and an updated synergy target from its Calavo deal, giving investors fresh numbers to reassess the stock. The fresh production guidance and synergy update land after a choppy stretch for Mission Produce’s stock, with the share price down 5.9% over the past week and 4.7% over the past month. The stock still shows a 90-day share price return of 8.4% and a 3-year total shareholder return...

Concentra Group Holdings Parent (CON) is back in focus after another earnings beat and the launch of a new occupational health center in Daytona Beach, Florida, a move tied directly to Florida network expansion. The latest Daytona expansion and leadership succession news arrive as Concentra Group Holdings Parent trades at US$35.53, with the share price return up 24.4% over 90 days and 83.1% year to date. The 1-year total shareholder return is 70.7%, suggesting momentum has been building...

FMC Corporation (FMC) moved into the spotlight after announcing that two RNA-based bioinsecticide candidates with AgroSpheres are progressing into global field trials across the United States, Brazil and Asia. For FMC, the RNA bioinsecticide milestone is landing against a weak price backdrop, with the share price down 28.87% year to date and posting a 1-year total shareholder return decline of 71.61% as dividend cuts and past setbacks continue to weigh on sentiment. Over three and five years,...

Attention on Dave (DAVE) has picked up as investors focus on the upcoming CashAI v5.5 rollout, which is expected to influence credit performance, advance sizes, loss rates, and overall profitability for the platform. Recent trading reflects that optimism. Dave’s 1 month share price return of 7.01% and 90 day share price return of 13.37% sit alongside a 62.42% year to date share price gain, while the 3 year total shareholder return is very large, which points to strong momentum built over...

Arthur J. Gallagher has given long term shareholders a 67.0% gain over the past 5 years, even though the share price has fallen over the past year. That track record puts the spotlight on a simple question for today’s buyers and holders: whether the current valuation can be explained by the returns the business earns on its capital. A 67.0% return over 5 years means Gallagher has already rewarded patient investors, which raises the bar for how strong its future capital returns need to be to...

JPMorgan Chase (NYSE:JPM) is expanding its digital assets team to build blockchain-based banking tools for Chase customers. The bank is rolling out new consumer-facing services that apply blockchain technology to everyday retail banking activities. Chase's Ultimate Rewards program now lets customers invest reward points directly into J.P. Morgan investment accounts. These hires and the new Invest Your Points feature only capture part of how JPMorgan is reshaping future retail finance...

Arcutis Biotherapeutics used a recent Morgan Stanley healthcare conference to reaffirm its 2026 revenue guidance of US$525 million to US$540 million and confirmed that the Phase 2 vitiligo trial remains scheduled for a fourth quarter data readout. This combination of steady revenue guidance and an on track dermatology pipeline update gives investors a clearer view of how Arcutis Biotherapeutics is trying to balance commercial execution with R&D progress. This article examines how Arcutis...

Honeywell Aerospace shares have climbed recently after a weak start to the year, which puts fresh attention on whether the current market price lines up with what the business can generate in cash over time. For investors watching the swings, the key issue is whether the stock’s recent move is backed up by the company’s underlying cash flows. The stock is still down 16.4% year to date, so the recent rebound raises the question of whether the current valuation now properly reflects the cash...

Blackstone has seen its share price fall sharply over the past year, which puts a spotlight on a different question for you as an investor. Is the current market value still in line with the returns the asset manager earns on the capital it puts to work across credit, private equity and real assets? The stock is down 30.8% over the past year, which raises the question of whether that decline now matches the returns Blackstone is generating on its invested capital. Recent moves to acquire...

Macy's (M) just paired a fresh quarter of earnings with updated guidance and a completed multiyear buyback, giving investors a dense cluster of new numbers to dissect around the stock. At around $21.64 per share, Macy's has slipped over the past month and quarter, with the 30 day and 90 day share price returns down 6.84% and 10.36%. At the same time, the 1 year total shareholder return of 27.25% and 3 year total shareholder return of about 2.3x hint that investors who stayed through earlier...

Constellation Energy (CEG) has moved into the spotlight after filing a detailed protest with the Federal Energy Regulatory Commission that challenges PJM’s proposed Interim Resource Adequacy Service and Large Load Registry framework. Recent trading in Constellation Energy reflects this push and pull between strong nuclear and data center demand tailwinds and fresh regulatory and acquisition headlines. The share price closed at US$262.8, with a 1-day share price return of 1.26%. However, the...

Comcast and Fastly announced a next generation partnership that embeds Fastly’s programmable edge software across Comcast’s nationwide network to push live streaming, security, and AI workloads closer to millions of Xfinity customers. The tie up effectively turns Comcast’s more than 200 AI powered edge compute centers into distribution points for Fastly’s platform, deepening Fastly’s role in high value, latency sensitive traffic such as live sports, gaming, and AI inference. We will look at...

Ball (BALL) is expanding its presence in India with a new beverage can facility in Uttar Pradesh. The plant is planned as a two line operation backed by customer contracts and is expected to start operations in 2029. Ball’s latest India expansion lands after a mixed price stretch, with the share price up 5.3% over 90 days and 13.9% year to date. The 1 year total shareholder return of 25.2% contrasts with a 5 year total shareholder return that remains materially lower. Scan how Ball’s India...

Berkshire Hathaway (NYSE:BRK.A) announced that Warren Buffett has stepped down as Chairman, effective immediately. Howard G. Buffett, Warren Buffett’s son and a long-serving Berkshire director, has been appointed as the new Chairman. Warren Buffett will remain involved with the conglomerate as Chairman Emeritus, a newly created honorary role. The handover of the Berkshire Hathaway chairmanship from Warren Buffett to Howard Buffett is only part of today’s story. We have also flagged 1 major...

Airbnb has delivered a 32.2% gain over the past year, even after recent share price weakness. This puts a fresh spotlight on a simple question for investors: Is the current US$165.93 price tag adequately supported by the cash the business is expected to generate over time? The 32.2% one year return has materially changed the entry price for new buyers. The key issue is whether that move matches the strength and durability of Airbnb's cash flows. The new US$250m Housing Accelerator fund and...

Ford Motor (NYSE:F) is recalling more than 223,000 F-150 pickup trucks over a potential fuel tank strap defect. The action covers F-150 models from the 2023 through 2027 model years that may have improperly secured fuel tank straps. Ford has identified a risk that affected fuel tanks could shift or detach, raising safety concerns for drivers and passengers. The F-150 fuel tank strap recall is significant. However, Ford's broader story extends well beyond this safety issue. We have also...

Constellium has put in a strong run over the past year, and the real question now is whether the current share price lines up with the cash flows the business is expected to generate. With the stock recently closing at US$26.19, investors are increasingly focused on what the company’s cash generation can reasonably support over time. The share price is up 60.1% over the past year, which puts the spotlight on whether that move is grounded in the cash the business can produce. The investment...

Waste Management has delivered a solid 50.4% share price gain over the past 5 years, yet the key issue for anyone looking at the stock today is how well that move lines up with the cash the business can generate. Recent leadership news only sharpens the focus on whether the current US$213.33 price is adequately grounded in the company’s cash flow profile. A 50.4% return over 5 years puts real weight on the question of whether Waste Management’s current valuation can be explained by its cash...

Watsco reported Q2 revenues of US$2.10b, which were 2.1% higher year on year but below analyst expectations, alongside a significant earnings per share shortfall versus consensus. The weak earnings print came as management pointed to a more conventional operating backdrop, where scale, OEM partnerships, and technology investments are expected to matter more for long term value creation. Investors will now assess how Watsco's investment narrative could be reshaped by the recent earnings miss...

Levi Strauss reported strong recent momentum in lifestyle categories such as tops, dresses, shorts, and premium women's apparel, supported by direct-to-consumer channels. Management raised fiscal 2026 revenue and earnings guidance to reflect this broader product mix. The push beyond core denim into higher value lifestyle pieces suggests Levi Strauss is leaning on direct-to-consumer sales to support margins and reduce reliance on wholesale partners. We will look at how Levi Strauss's...

Coca-Cola has been a strong performer over the past few years, and the stock now trades with a long run of gains behind it. With that backdrop, the question is whether the current share price is still aligned with the cash flows the business is expected to generate. Over the past 5 years, Coca-Cola has delivered an 88.6% total return. This puts real pressure on investors to check whether the current valuation still lines up with the cash its business can produce. Planned US$10b of...

Scholar Rock Holding (SRRK) just received FDA approval for ISEMBYLD, a muscle targeted therapy for spinal muscular atrophy patients already on SMN2 treatments. This has prompted a special call that puts fresh attention on the stock. Scholar Rock Holding’s share price has cooled after the FDA decision, with the stock down 12% over the past week and about 10% over the last month. However, a 15% year to date share price gain and a roughly 51% 1 year total shareholder return show momentum is...